Side-by-side comparison
IGF-1 DES vs LL-37 Truncated Variants (KR-12 / KS-30)
Truncated IGF-1 with localized hypertrophic action; favored for site-specific bodybuilding research. versus Shorter active fragments of LL-37 (KR-12, KS-30) with retained antimicrobial activity but lower toxicity.
IGF-1 DES
PerformanceTruncated IGF-1 with localized hypertrophic action; favored for site-specific bodybuilding research.
Top benefits
- ✓Localized muscle hyperplasia
- ✓Stronger receptor binding than wild-type
LL-37 Truncated Variants (KR-12 / KS-30)
RecoveryShorter active fragments of LL-37 (KR-12, KS-30) with retained antimicrobial activity but lower toxicity.
Top benefits
- ✓Antimicrobial activity preserved
- ✓Lower hemolysis vs full LL-37
- ✓Wound healing research
| Attribute | IGF-1 DES | LL-37 Truncated Variants (KR-12 / KS-30) |
|---|---|---|
| Category | Performance | Recovery |
| Type | protein | linear |
| Chain length | 67 aa | 12 aa |
| Formula | modified IGF-1 | KR-12 fragment of LL-37 |
| Common dose | 20–50 mcg | Not established |
| Frequency | Post-workout | N/A |
| Top benefit | Localized muscle hyperplasia | Antimicrobial activity preserved |
| Top side-effect | Hypoglycemia risk | Localized irritation (topical) |
⚠
Educational use only
This calculator is provided for research and educational purposes. Outputs are derived from the values you enter. Always verify your math and consult a licensed physician before acting on any result.